Mark Sabag - May 8, 2025 Form 4 Insider Report for TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)

Role
Executive Vice President, International Markets Commercial
Signature
/s/ Dov Bergwerk as attorney-in-fact for Mark Sabag
Stock symbol
TEVA
Transactions as of
May 8, 2025
Transactions value $
-$6,097,304
Form type
4
Date filed
5/12/2025, 04:00 PM
Previous filing
Mar 7, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Sabag Mark Executive Vice President, International Markets Commercial C/O TEVA PHARMACEUTICAL INDUSTRIES LTD., 124 DVORA HANEVI'A ST.,, TEL AVIV, ISRAEL /s/ Dov Bergwerk as attorney-in-fact for Mark Sabag 2025-05-12 0001721442

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TEVA Ordinary Shares Sale -$6.1M -338K -69.12% $18.04 151K May 8, 2025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.865 to $18.265, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price.

Remarks:

Executive Vice President, International Markets Commercial